(-0.57%) 5 020.00 points
(-0.47%) 37 827 points
(-0.81%) 17 406 points
(0.17%) $82.87
(-0.68%) $1.745
(0.07%) $2 399.60
(0.14%) $28.42
(-0.37%) $951.00
(0.00%) $0.939
(0.13%) $11.06
(-0.02%) $0.804
(-0.36%) $93.56
Live Chart Being Loaded With Signals
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally...
Stats | |
---|---|
Today's Volume | 120.00 |
Average Volume | 240.00 |
Market Cap | 65.86B |
EPS | €0 ( 2024-02-12 ) |
Next earnings date | ( €0 ) 2024-05-01 |
Last Dividend | €0.375 ( 2023-07-20 ) |
Next Dividend | €0 ( N/A ) |
P/E | 30.16 |
ATR14 | €0 (0.00%) |
Zoetis Inc Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Zoetis Inc Financials
Annual | 2023 |
Revenue: | €8.54B |
Gross Profit: | €5.98B (70.03 %) |
EPS: | €5.08 |
Q4 | 2023 |
Revenue: | €2.21B |
Gross Profit: | €1.49B (67.10 %) |
EPS: | €0 |
Q3 | 2023 |
Revenue: | €2.15B |
Gross Profit: | €1.51B (70.34 %) |
EPS: | €1.290 |
Q2 | 2023 |
Revenue: | €2.18B |
Gross Profit: | €1.57B (72.16 %) |
EPS: | €1.450 |
Financial Reports:
No articles found.
Zoetis Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€0.325 (N/A) |
€0.325 (N/A) |
€0.375 (N/A) |
€0.375 (N/A) |
€0.375 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €0.200 | 2020-01-16 |
Last Dividend | €0.375 | 2023-07-20 |
Next Dividend | €0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 15 | -- |
Total Paid Out | €4.23 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 4.04 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.74 | |
Div. Directional Score | 7.96 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
MUB.DE | Ex Dividend Junior | 2023-08-11 | Annually | 0 | 0.00% | |
AHOG.DE | Ex Dividend Knight | 2023-08-11 | Semi-Annually | 0 | 0.00% | |
VVV3.DE | Ex Dividend Junior | 2023-06-22 | Annually | 0 | 0.00% | |
GDX.DE | Ex Dividend Knight | 2023-10-05 | Quarterly | 0 | 0.00% | |
PBB.DE | Ex Dividend Junior | 2023-05-26 | Annually | 0 | 0.00% | |
BLQA.DE | Ex Dividend Knight | 2023-09-07 | Quarterly | 0 | 0.00% | |
HOT.DE | Ex Dividend Knight | 2023-04-27 | Annually | 0 | 0.00% | |
SAP.DE | Ex Dividend Knight | 2023-05-12 | Annually | 0 | 0.00% | |
CRIN.DE | Ex Dividend Junior | 2023-04-24 | Annually | 0 | 0.00% | |
KLA.DE | Ex Dividend Knight | 2023-08-14 | Quarterly | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.274 | 1.500 | 4.51 | 6.77 | [0 - 0.5] |
returnOnAssetsTTM | 0.164 | 1.200 | 4.53 | 5.44 | [0 - 0.3] |
returnOnEquityTTM | 0.488 | 1.500 | 5.68 | 8.53 | [0.1 - 1] |
payoutRatioTTM | 0.295 | -1.000 | 7.05 | -7.05 | [0 - 1] |
currentRatioTTM | 3.36 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 1.770 | 0.800 | 4.30 | 3.44 | [0.8 - 2.5] |
cashRatioTTM | 1.079 | 1.500 | 5.11 | 7.67 | [0.2 - 2] |
debtRatioTTM | 0.473 | -1.500 | 2.12 | -3.18 | [0 - 0.6] |
interestCoverageTTM | 13.61 | 1.000 | 6.07 | 6.07 | [3 - 30] |
operatingCashFlowPerShareTTM | 5.09 | 2.00 | 8.30 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 3.51 | 2.00 | 8.25 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 1.352 | -1.500 | 4.59 | -6.89 | [0 - 2.5] |
grossProfitMarginTTM | 0.700 | 1.000 | 1.662 | 1.662 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.381 | 1.000 | 4.39 | 4.39 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.348 | 1.000 | 9.18 | 9.18 | [0.2 - 2] |
assetTurnoverTTM | 0.598 | 0.800 | 9.35 | 7.48 | [0.5 - 2] |
Total Score | 10.17 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 32.39 | 1.000 | 6.83 | 0 | [1 - 100] |
returnOnEquityTTM | 0.488 | 2.50 | 7.23 | 8.53 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 3.51 | 2.00 | 8.83 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.947 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 5.09 | 2.00 | 8.30 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.295 | 1.500 | 7.05 | -7.05 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.275 | 1.000 | 5.62 | 0 | [0.1 - 0.5] |
Total Score | 5.74 |
Zoetis Inc
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators